Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today […]
Altair Medical Secures $3.1m in Pre-Series A financing
UK based Altair Medical today announced it has secured £2.25m ($3.1m) of Pre-Series A funding […]
Microsoft Accelerates Industry Cloud Strategy for Healthcare with the Acquisition of Nuance
Microsoft Corp and Nuance Communications, Inc. today announced they have entered into a definitive agreement […]
Caption Health Announces Steve Cashman as New President and CEO
Caption Health, a leading medical artificial intelligence (AI) company driving better health outcomes by increasing […]
Axa Collaborates with Microsoft to Create the next Generation Standard of Health and Well-being Services
AXA announced it is collaborating with Microsoft to build a digital healthcare platform, enabling a […]
Diogo Rau to Join Lilly as Senior Vice-president and Chief Information and Digital Officer
Eli Lilly and Company announced today that Diogo Rau will join the company on May 17, 2021 as senior vice-president […]
KD Pharma Group Acquires Phytoextract and CBD Manufacturing Assets
The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The […]
Calixar Invests €1 Million in Pipeline of Highly Druggable Membrane Protein Targets and Native Antigens
Calixar, a biotechnology company with ten years expertise in the isolation of fully native membrane […]
Sanofi Acquires Tidal Therapeutics
Sanofi today acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel […]
Zedsen Closes $12M Series B, Expands Team with Appointment of New CTO
Zedsen, a UK health tech company with a revolutionary non-invasive technology that helps consumers understand […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more